MedTrace Logo

Impact of Maltodextrin on Glycemic and Hemodynamic Management During Cesarean Section

NCT05553756 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-09-23

No results posted yet for this study

Summary

The goal is to evaluate the glycemic and hemodynamic stability in patients undergoing caesarean section in patients treated with maltodextrins two hours before the cesarean section

Conditions

  • Cesarean Section Complications

Interventions

DIETARY_SUPPLEMENT

Maltodextrin

200 ml maltodextrin given 2 hours before cesarean section

Sponsors & Collaborators

  • Casa Sollievo della Sofferenza IRCCS

    collaborator OTHER

  • University of Foggia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-13
Primary Completion
2022-11-30
Completion
2022-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05553756 on ClinicalTrials.gov